599
Participants
Start Date
January 8, 2009
Primary Completion Date
April 26, 2012
Study Completion Date
April 26, 2012
alitretinoin
Patients receive alitretinoin 30mg one capsule daily for up to 24 weeks
Placebo
Patients receive matching placebo for up to 24 weeks
St.Luke's/Roosevelt Hospital Center, New York
Mount Sinai School of Medicine Clinical Dermatology, New York
Derm Research Center of New York Inc., Stony Brook
Helendale Dermatology and Medical Spa, Rochester
University of Pittsburgh Medical Center, Pittsburgh
Paddington Testing Co.Inc, Philadelphia
George Washington University - Medical Faculty Associates, Washington D.C.
Virginia Clinical Research Inc., Norfolk
Wake Forrest University School of Medicine, Winston-Salem
Azalea Research Center, Wilmington
Toccoa Clinic Medical Associates, Toccoa
Park Avenue Dermatology, PA, Orange Park
Palm Beach Research Center, West Palm Beach
University of Alabama, Birmingham, Birmingham
Tennessee Clinical Research Center, Nashville
Indiana University Dermatology, Indianapolis
Dermatology Associates of Kingsport, Kingsport
Dermatology Specialists, Louisville
Derm Research, PLLC, Louisville
Bernstein Clinical Research Center, Cincinnati
Dermatology Center of Indiana/Indiana Clinical Trials Center, Plainfield
The Dermatology Center, New Albany
Deaconess Clinic, Inc., Evansville
Hamzavi Dermatology Clinic, Fort Gratiot
Grekin Skin Institute, Warren
Silverton Skin Institute, Grand Blanc
Madison Skin & Research Inc., Madison
Minnesota Clinical Studies Research Center, Fridley
MAPS Applied Research Center, Edina
Michael Bukhalo MD, Arlington Heights
Dundee Dermatology, West Dundee
Schaumburg Dermatology, Schaumburg
Dermassociates, Ltd, Belleville
Washington University Dermatology Research, St Louis
Kansas City Dermatology, PA, Overland Park
American Dermatology Association, Shawnee Mission
Kansas Medical Clinic, Topeka
South Lincoln Dermatology, Lincoln
Tulane University Health Sciences, Dermatology Dept, New Orleans
Dermatology Research of Arkansas, Little Rock
Hull Dermatology, Rogers
Johnson Dermatology, Fort Smith
Modern Research Associates, Dallas
Academy of Clinical Research, Arlington
Center for Clinical Studies, Houston
Dermatology Clinical Research Center of San Antonio, San Antonio
Center for Clinical Studies, Webster
Western State Clinical Research Inc., Wheat Ridge
Longmont Clinic, P.C., Longmont
Saltzer Medical Group, Nampa
Radiant Research Inc., Tucson
Dermatology Research Associates, Los Angeles
Laser and Dermatology Center, Marina del Rey
Shahram Jacobs, MD, Inc., Encino
University of California, San Diego Dermatology Clinical Trials Unit, La Jolla
Therapeutics Clinical Research, San Diego
Integrated Research Group, Riverside
Stanford University Dept of Dermatology, Stanford
East Bay Psoriasis Treatment Center, San Ramon
Solano Clinical Research, Dow Pharmaceutical Sciences, Vallejo
University of California, Davis, Sacramento
Oregon Dermatology and Research Center, Portland
Oregon Health and Science University, Portland
Dermatology and Laser Center NW, Bellingham
Premier Clinical Research, Seattle
Dartmouth-Hitchcock Medical Center, Lebanon
UMDNJ - Robert Wood Johnson School of Medicine, Dermatology, Somerset
University of North Carolina, Dermatology Department, Chapel Hill
Rhode Island Hospital, Providence
Fletcher Allen Health Care, Burlington
Collaborators (1)
Basilea Pharmaceutica
INDUSTRY
Stiefel, a GSK Company
INDUSTRY